Evidence map›Paper›PMID 25284784›Full record

ArticleCell reports2014

De novo insertions and deletions of predominantly paternal origin are associated with autism spectrum disorder.

Shan Dong, Michael F Walker, Nicholas J Carriero, Michael DiCola, A Jeremy Willsey, Adam Y Ye, Zainulabedin Waqar, Luis E Gonzalez, John D Overton, Stephanie Frahm and 21 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 3 pooled it
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 3 syntheses or guidelines pooled it, 181 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Autism risk genes converge onbioRxiv : the preprint server for biology · 2025
    Article
  11. Review
  12. Article
  13. Clinical and genetic analysis of a case of OZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. The contributions of rare inherited and polygenic risk to ASD in multiplex families.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  19. Review
  20. Candidate biomarkers in psychiatric disorders: state of the field.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2023
    Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 8 institutions in 2 countries.

Shan DongCenter for Bioinformatics, State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing 100871, People's Republic of China; Department of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA.
Michael F WalkerDepartment of Psychiatry, University of California, San Francisco, San Francisco, CA 94158, USA.
Nicholas J CarrieroBiomedical High Performance Computing Center, W.M. Keck Biotechnology Resource Laboratory, Department of Computer Science, Yale University, New Haven, CT 06520, USA.
Michael DiColaBionomics Research and Technology, Environmental and Occupational Health Sciences Institute, Rutgers University, 170 Frelinghuysen Road, Piscataway, NJ 08854, USA.
A Jeremy WillseyDepartment of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Psychiatry, University of California, San Francisco, San Francisco, CA 94158, USA.
Adam Y YeCenter for Bioinformatics, State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing 100871, People's Republic of China; National Institute of Biological Sciences, Beijing 102206, People's Republic of China.
Zainulabedin WaqarChild Study Center, Yale University School of Medicine, New Haven, CT 06520, USA.
Luis E GonzalezChild Study Center, Yale University School of Medicine, New Haven, CT 06520, USA.
John D OvertonYale Center for Genomic Analysis, Yale University School of Medicine, New Haven, CT 06520, USA; Regeneron Genetics Center, 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA.
Stephanie FrahmBionomics Research and Technology, Environmental and Occupational Health Sciences Institute, Rutgers University, 170 Frelinghuysen Road, Piscataway, NJ 08854, USA.
John F KeaneyDepartment of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT 06520, USA.
Nicole A TeranChild Study Center, Yale University School of Medicine, New Haven, CT 06520, USA.
Jeanselle DeaDepartment of Psychiatry, University of California, San Francisco, San Francisco, CA 94158, USA.
Jeffrey D MandellDepartment of Psychiatry, University of California, San Francisco, San Francisco, CA 94158, USA.
Vanessa Hus BalDepartment of Psychiatry, University of California, San Francisco, San Francisco, CA 94158, USA.
Catherine A SullivanChild Study Center, Yale University School of Medicine, New Haven, CT 06520, USA.
Nicholas M DiLulloChild Study Center, Yale University School of Medicine, New Haven, CT 06520, USA.
Rehab O KhalilDepartment of Psychiatry, University of California, San Francisco, San Francisco, CA 94158, USA; Department of Research on Children with Special Needs, National Research Center, Cairo 11787, Egypt.
Jake GockleyDepartment of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA.
Zafer YukselDepartment of Medical Genetics, Gulhane Military Medical Academy, Ankara 06010, Turkey.
Sinem M SertelDepartment of Molecular Biology and Genetics, Bilkent University, Ankara 06800, Turkey.
A Gulhan Ercan-SencicekDepartment of Neurosurgery, Yale Neurogenetics Program, Yale University School of Medicine, New Haven, CT 06520, USA.
Abha R GuptaChild Study Center, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06520, USA.
Shrikant M ManeYale Center for Genomic Analysis, Yale University School of Medicine, New Haven, CT 06520, USA.
Michael SheldonDepartment of Genetics and the Human Genetics Institute, Rutgers University, 145 Bevier Road, Room 136, Piscataway, NJ 08854, USA.
Andrew I BrooksBionomics Research and Technology, Environmental and Occupational Health Sciences Institute, Rutgers University, 170 Frelinghuysen Road, Piscataway, NJ 08854, USA.
Kathryn RoederDepartment of Statistics, Carnegie Mellon University, Pittsburgh, PA 15213, USA; Ray and Stephanie Lane Center for Computational Biology, Carnegie Mellon University, Pittsburgh, PA 15213, USA.
Bernie DevlinDepartment of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Matthew W StateDepartment of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Psychiatry, University of California, San Francisco, San Francisco, CA 94158, USA; Child Study Center, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06520, USA. Electronic address: matthew.state@ucsf.edu.
Liping WeiCenter for Bioinformatics, State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing 100871, People's Republic of China; National Institute of Biological Sciences, Beijing 102206, People's Republic of China. Electronic address: weilp@mail.cbi.pku.edu.cn.
Stephan J SandersDepartment of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Psychiatry, University of California, San Francisco, San Francisco, CA 94158, USA. Electronic address: stephan.sanders@ucsf.edu.
Yale University · USUniversity of California, San Francisco · USEnvironmental and Occupational Health Sciences Institute · USRutgers, The State University of New Jersey · USBilkent University · TRTurkish Armed Forces · TRUniversity of Pittsburgh · USW. M. Keck Foundation · US

Funding

Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI MEGAN C KING · 1985 to 2026
$85.0M
Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
GENETICS AND GENOMICS OF HUMAN DISEASET32HD007149 · NICHD · YALE UNIVERSITY · PI James P Noonan · 1985 to 2026
$8.2M
Genetics Association in Schizophrenia and Other DisordersR37MH057881 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DEVLIN, BERNIE · 2013 to 2022
$5.4M
4/4 The Autism Sequencing Consortium: Autism gene discovery in the >20,000 exomes (supplement)U01MH100239 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STATE, MATTHEW W. · 2013 to 2015
$3.0M
Yale University Clinical and Translational Science Award ProgramKL2TR000140 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$2.9M
CIHRHoward Hughes Medical InstituteNCATS NIH HHS KL2 TR000140NCATS NIH HHS UL1 TR000142NICHD NIH HHS T32 HD007149NIMH NIH HHS R37 MH057881NIMH NIH HHS U01 MH100239
6 · The paper itself

Abstract

Whole-exome sequencing (WES) studies have demonstrated the contribution of de novo loss-of-function single-nucleotide variants (SNVs) to autism spectrum disorder (ASD). However, challenges in the reliable detection of de novo insertions and deletions (indels) have limited inclusion of these variants in prior analyses. By applying a robust indel detection method to WES data from 787 ASD families (2,963 individuals), we demonstrate that de novo frameshift indels contribute to ASD risk (OR = 1.6; 95% CI = 1.0-2.7; p = 0.03), are more common in female probands (p = 0.02), are enriched among genes encoding FMRP targets (p = 6 × 10(-9)), and arise predominantly on the paternal chromosome (p < 0.001). On the basis of mutation rates in probands versus unaffected siblings, we conclude that de novo frameshift indels contribute to risk in approximately 3% of individuals with ASD. Finally, by observing clustering of mutations in unrelated probands, we uncover two ASD-associated genes: KMT2E (MLL5), a chromatin regulator, and RIMS1, a regulator of synaptic vesicle release.

Indexed as

Frameshift MutationSequence DeletionChildChild Development Disorders, PervasiveDNADNA-Binding ProteinsFemaleFragile X Messenger Ribonucleoprotein 1GTP-Binding ProteinsHumansMaleNerve Tissue ProteinsPedigreePhenotypeSex FactorsDNADNA-Binding ProteinsFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1GTP-Binding ProteinsKMT2E protein, humanNerve Tissue ProteinsRIMS1 protein, human

Identifiers

PMID25284784
PMCPMC4194132
OpenAlexW2059327830

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.